NCT02032771View on ClinicalTrials.gov

Impact of M22 Synergistic Sequential Treatment (SST)

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Improvement of Wrinkles/Elastosis and/or Pigmentation
Interventions
DEVICE

M22 IPL and ResurFX

The procedure will include an intense pulse light (M22 IPL) treatment followed by fractional non-ablative (M22 ResurFX) treatment.

Trial Locations (2)

32801

Knight Dermatology Institute, Orlando

54329

Konz

All Listed Sponsors
lead

Lumenis Be Ltd.

INDUSTRY

NCT02032771 - Impact of M22 Synergistic Sequential Treatment (SST) | Biotech Hunter | Biotech Hunter